Sanofi Thailand Wins Seventh Consecutive AmCham CSI Gold Award

Sanofi Thailand has won the Corporate Social Impact Award (CSI) 2026 Gold level from the American Chamber of Commerce in Thailand (AmCham Thailand) for the seventh consecutive year, reinforcing its commitment to sustainable business practices and improving the quality of life for Thai people across all dimensions. The prestigious award ceremony was held on November 9, 2026, at the Siam Kempinski Hotel in Bangkok. The award reflects Sanofi's unwavering dedication to conducting business with social responsibility and its tangible efforts to enhance the quality of life for Thais and promote sustainability.

Sanofi focuses not only on discovering pharmaceutical and vaccine innovations but also on creating positive social impact throughout its operations, aligned with its core mission: 'We Chase the Miracles of Science to Improve People's Lives.' Sanofi integrates social impact into its workflow, from strengthening healthcare access to raising health awareness and promoting the importance of life-course immunization. The company views major respiratory diseases such as influenza and respiratory syncytial virus (RSV) as preventable and manageable with effective medical innovations, preventing them from escalating into crises. Previously, the company has integrated cooperation with network partners such as the Bangkok Metropolitan Administration's Medical and Health Departments and the Department of Medical Services, Ministry of Public Health, to jointly strengthen Thailand's preventive public health efforts.

Charles Tollet, Head of Cooperation for Thailand, Malaysia, and Singapore, General Medicines Business Unit, Sanofi, spoke on the organization's sustainability direction: 'At Sanofi, we believe true business success must grow hand-in-hand with creating sustainability for society and the environment. Our ability to sustain social projects in Thailand for so long is because we see the healthcare ecosystem holistically. We not only strive to deliver equitable and effective treatment access to patients but also prioritize building preventive health awareness in communities. These commitments reflect our overall vision to drive Thai society forward to progress, strength, and sustainable growth together.'

Wansiri Chuenjitkulthaworn, Country Operations Lead, Vaccines Business Unit, Sanofi Thailand, expressed pride on behalf of the organization: 'The AmCham CSI Gold Award, which we have been trusted to receive for seven consecutive years, is the highest pride for Sanofi's executives and all employees. It reflects the continuous collaborative work over many years, from volunteer employees who dedicate their time to field work, and partners from all sectors who jointly drive projects to fruition, creating tangible results.'